Robert Lechleider Insider Trades & Stock Holdings

Chief Medical Officer · Immunome, Inc. · Latest filing Jun 25, 2026

Robert Lechleider, Chief Medical Officer at Immunome, Inc. has 2 Form 4 trades on file since Jun 25, 2026. Latest filing: disposed of 55K shares of $IMNM on Jun 25, 2026.

Trades on file

2

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 25, 2026

All insider trades by Robert Lechleider

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$IMNM	Sell (Option exercise)	55K	$0	—			+21.7%	+16.4%		Chief Medical Officer		Read
Jun 25, 2026	$IMNM	Buy (Option exercise)	55K	$8.73	$480.15K			+21.7%	+16.4%		Chief Medical Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Robert Lechleider traded

• $IMNM

Frequently asked questions

What was Robert Lechleider's latest insider trade?

disposed of 55K shares of $IMNM on Jun 25, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.